Biblio
The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance. Redox Biol. 2023;67:102931.
. .
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer. Redox Biol. 2019;24:101225.
. Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. Proc Natl Acad Sci U S A. 2013.